<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6726D03A-217B-461A-8939-2057211DF5A5"><gtr:id>6726D03A-217B-461A-8939-2057211DF5A5</gtr:id><gtr:name>MRC North West Hub for Trials Methodology Research</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EC23DA53-CA73-4104-A3F6-2A9523484E69"><gtr:id>EC23DA53-CA73-4104-A3F6-2A9523484E69</gtr:id><gtr:name>Queen's University of Belfast</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Belfast</gtr:line4><gtr:line5>County Antrim</gtr:line5><gtr:postCode>BT7 1NN</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7008F77D-D7F3-4558-AEE7-9195B7890A2D"><gtr:id>7008F77D-D7F3-4558-AEE7-9195B7890A2D</gtr:id><gtr:name>Moorfields Eye Hospital NHS Foundation Trust</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:department>Social Medicine</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6726D03A-217B-461A-8939-2057211DF5A5"><gtr:id>6726D03A-217B-461A-8939-2057211DF5A5</gtr:id><gtr:name>MRC North West Hub for Trials Methodology Research</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EC23DA53-CA73-4104-A3F6-2A9523484E69"><gtr:id>EC23DA53-CA73-4104-A3F6-2A9523484E69</gtr:id><gtr:name>Queen's University of Belfast</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Belfast</gtr:line4><gtr:line5>County Antrim</gtr:line5><gtr:postCode>BT7 1NN</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7008F77D-D7F3-4558-AEE7-9195B7890A2D"><gtr:id>7008F77D-D7F3-4558-AEE7-9195B7890A2D</gtr:id><gtr:name>Moorfields Eye Hospital NHS Foundation Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/3BA68F56-78DF-4CF9-889F-0DE087B1EA6C"><gtr:id>3BA68F56-78DF-4CF9-889F-0DE087B1EA6C</gtr:id><gtr:firstName>Nicola</gtr:firstName><gtr:otherNames>Jane</gtr:otherNames><gtr:surname>Mills</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G106%2F1092"><gtr:id>D1F07F07-CA55-489E-AF54-F765BDE2271C</gtr:id><gtr:title>Investigating and understanding the role of patient preferences in trial participation and outcome</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G106/1092</gtr:grantReference><gtr:abstractText>Sometimes doctors do not know the best treatment to give a patient because there is not enough scientific evidence to say which is best. In this case medical trials are conducted to compare the different treatments. To compare treatments accurately in trials patients should have their treatment selected at random (i.e. by chance). Some patients, however, prefer to choose their own treatment but this causes problems for those who analyse the data. This study intends to find out more about patients who prefer to choose their treatment by seeing if they differ from those who have their treatment randomly allocated and if they achieve greater benefits from the treatment. The study will also explore why patients have preferences for treatment and if this stops them from agreeing to have their treatment selected at random. Data will be collected by asking patients to complete questionnaires, by talking to them and by tape recording their consultation with the doctor. By understanding more about the role of patient preferences in trial participation, scientists will be able to conduct and analyse trials more accurately and thus have a better idea of what treatment is best when there is doubt.</gtr:abstractText><gtr:technicalSummary>Overall aim: To investigate and understand the role of patient preferences in trial participation and outcome through the use of qualitative and quantitative research methods.

Design: Stage I will involve a review of the relevant literature. Stage II will explore the basis upon which patient preferences for treatment are formed, whether they change over time, how they are presented and dealt with during trial recruitment, and what influence they have in facilitating or preventing recruitment to trials. Stage III will examine social and demographic differences between patients who choose a preferred treatment and those who agree to be randomised. Stage IV will compare symptomatic and quality of life measures between the two groups of patients to indicate the impact of patient preferences on outcome. Stage V will investigate how information from preference arms can be used in interpreting results in randomised trials. 

Methods: The study will use data from a trial of treatments for localised prostate cancer (ProtecT study). Stage II will utilise audiotape recorded data from in-depth interviews with patients and from their consultation with the recruiting clinician. Methods of analysis will involve constant comparison and conversation analysis. Stage III and IV will extract data from patient completed questionnaires. Logistic regression will be used to examine social and demographic differences (Stage III), and to assess the impact of patient preferences on quality of life outcomes (Stage IV). Stage V will involve a review of statistical methods for analysing a preference group in a trial.</gtr:technicalSummary><gtr:fund><gtr:end>2009-03-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2002-09-30</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>163529</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Network of Hubs for Trials Methodology Research (HTMR)</gtr:department><gtr:description>MRC Hubs for Trials Methodology Research Trial Recruitment Working Group</gtr:description><gtr:id>A33ABD24-FAB0-4746-9D48-AAC18ACFC0D9</gtr:id><gtr:impact>Document on &amp;quot;Tips for optimising recruitment of patients to randomised clinical trials&amp;quot;; national cross hub workshop on recruitment into surgical trials; national cross hub workshop on the value of integrating qualitative research in randomised trials; session on trial recruitment at the National HTMR annual meeting; preparation for a forthcoming national cross hub workshop with clinical trial unit directors on recruitment and retention in randomised trials.</gtr:impact><gtr:outcomeId>Vi9EUEQ5sCo-4</gtr:outcomeId><gtr:partnerContribution>Contributed to all outputs to date</gtr:partnerContribution><gtr:piContribution>I lead and contribute to the working group</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Oxford Hub</gtr:department><gtr:description>MRC Hubs for Trials Methodology Research Trial Recruitment Working Group</gtr:description><gtr:id>B9FD4F28-091B-4932-A22D-95613F3CC9B6</gtr:id><gtr:impact>Document on &amp;quot;Tips for optimising recruitment of patients to randomised clinical trials&amp;quot;; national cross hub workshop on recruitment into surgical trials; national cross hub workshop on the value of integrating qualitative research in randomised trials; session on trial recruitment at the National HTMR annual meeting; preparation for a forthcoming national cross hub workshop with clinical trial unit directors on recruitment and retention in randomised trials.</gtr:impact><gtr:outcomeId>Vi9EUEQ5sCo-3</gtr:outcomeId><gtr:partnerContribution>Contributed to all outputs to date</gtr:partnerContribution><gtr:piContribution>I lead and contribute to the working group</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Moorfields Eye Hospital NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>NIHR Moorfields Biomedical Research Centre</gtr:department><gtr:description>The ECHoES trial</gtr:description><gtr:id>EEDB4E1E-1B53-44A5-BCC2-A65C997406DF</gtr:id><gtr:impact>An NIHR HTA Programme Clinical Evaluation and Trials proposal was accepted for funding and is currently being undertaken. Multidisciplinary collaboration involving: ophthalomology, health services research, health economics, epidemiology, vision and vascular science, qualitative research</gtr:impact><gtr:outcomeId>Ubg6TNKTKgU-6</gtr:outcomeId><gtr:partnerContribution>Collectively the partners put together an HTA proposal to assess the effectiveness of community versus hospital eye service follow-up for patients with neovascular age related macular degeneration.</gtr:partnerContribution><gtr:piContribution>An NIHR HTA Programme Clinical Evaluation and Trials proposal has been funded to assess the effectiveness of shared care for patients with neovascular age related macular degeneration. I devised a qualitative component as part of this proposal to determine the views of health professionals and patients on the devolving of monitoring from hospital based ophthalmologists to community based optometrists to assess the need for re-treatment.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Health Economics Research Centre</gtr:department><gtr:description>The ECHoES trial</gtr:description><gtr:id>B28F5793-5387-47BB-BBE3-C02A7EB84BEA</gtr:id><gtr:impact>An NIHR HTA Programme Clinical Evaluation and Trials proposal was accepted for funding and is currently being undertaken. Multidisciplinary collaboration involving: ophthalomology, health services research, health economics, epidemiology, vision and vascular science, qualitative research</gtr:impact><gtr:outcomeId>Ubg6TNKTKgU-4</gtr:outcomeId><gtr:partnerContribution>Collectively the partners put together an HTA proposal to assess the effectiveness of community versus hospital eye service follow-up for patients with neovascular age related macular degeneration.</gtr:partnerContribution><gtr:piContribution>An NIHR HTA Programme Clinical Evaluation and Trials proposal has been funded to assess the effectiveness of shared care for patients with neovascular age related macular degeneration. I devised a qualitative component as part of this proposal to determine the views of health professionals and patients on the devolving of monitoring from hospital based ophthalmologists to community based optometrists to assess the need for re-treatment.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen's University Belfast</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Experimental Medicine</gtr:department><gtr:description>The ECHoES trial</gtr:description><gtr:id>6DBAFFD8-A8E0-406F-ACDF-81F926CABC0E</gtr:id><gtr:impact>An NIHR HTA Programme Clinical Evaluation and Trials proposal was accepted for funding and is currently being undertaken. Multidisciplinary collaboration involving: ophthalomology, health services research, health economics, epidemiology, vision and vascular science, qualitative research</gtr:impact><gtr:outcomeId>Ubg6TNKTKgU-1</gtr:outcomeId><gtr:partnerContribution>Collectively the partners put together an HTA proposal to assess the effectiveness of community versus hospital eye service follow-up for patients with neovascular age related macular degeneration.</gtr:partnerContribution><gtr:piContribution>An NIHR HTA Programme Clinical Evaluation and Trials proposal has been funded to assess the effectiveness of shared care for patients with neovascular age related macular degeneration. I devised a qualitative component as part of this proposal to determine the views of health professionals and patients on the devolving of monitoring from hospital based ophthalmologists to community based optometrists to assess the need for re-treatment.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MRC North West Hub for Trials Methodology Research</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>MRC Hubs for Trials Methodology Research Trial Recruitment Working Group</gtr:description><gtr:id>2E66E958-977F-496E-AB5D-F4516081584B</gtr:id><gtr:impact>Document on &amp;quot;Tips for optimising recruitment of patients to randomised clinical trials&amp;quot;; national cross hub workshop on recruitment into surgical trials; national cross hub workshop on the value of integrating qualitative research in randomised trials; session on trial recruitment at the National HTMR annual meeting; preparation for a forthcoming national cross hub workshop with clinical trial unit directors on recruitment and retention in randomised trials.</gtr:impact><gtr:outcomeId>Vi9EUEQ5sCo-1</gtr:outcomeId><gtr:partnerContribution>Contributed to all outputs to date</gtr:partnerContribution><gtr:piContribution>I lead and contribute to the working group</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bristol</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Social and Community Medicine</gtr:department><gtr:description>SMILE feasibility and main trial (intervention for CFS/ME)</gtr:description><gtr:id>82F87EB7-AD4F-431C-936D-69AB265EAA84</gtr:id><gtr:impact>The research proposal was successful and research commenced in September 2010. The feasibility study converted to a main trial from October 2012. Multi-disciplinary research comprising paediatrics, CFS/ME clinical research, qualitative research, Health economics, health services research and epidemiology</gtr:impact><gtr:outcomeId>AFA90CA5CC7-1</gtr:outcomeId><gtr:partnerContribution>Colleagues from the Centre for Child and Adolescent Health, University of Bristol, designed and undertook a feasibility study to assess the feasibility and acceptability of an RCT comparing interventions for children with chronic fatigue syndrome or myalgic encephalopathy.</gtr:partnerContribution><gtr:piContribution>Work arising from my MRC funded fellowship resulted in the formal collaboration with colleagues from the Centre for Child and Adoloescent Health and a proposal to assess the feasibility and acceptability of an RCT comparing interventions for children with chronic fatigue syndrome or myalgic encephalopathy. My fellowship work in particular highlighted the importance of analysing recruitment appointments to maximise trial recruitment and this method was integrated into the research proposal resulting from the collaboration. I am responsible for designing and overseeing the qualitative component of this feasibility trial.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bristol</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Clinical Sciences</gtr:department><gtr:description>The ECHoES trial</gtr:description><gtr:id>6E45FDE0-F9C8-4576-B8A1-F45A0C387EAA</gtr:id><gtr:impact>An NIHR HTA Programme Clinical Evaluation and Trials proposal was accepted for funding and is currently being undertaken. Multidisciplinary collaboration involving: ophthalomology, health services research, health economics, epidemiology, vision and vascular science, qualitative research</gtr:impact><gtr:outcomeId>Ubg6TNKTKgU-2</gtr:outcomeId><gtr:partnerContribution>Collectively the partners put together an HTA proposal to assess the effectiveness of community versus hospital eye service follow-up for patients with neovascular age related macular degeneration.</gtr:partnerContribution><gtr:piContribution>An NIHR HTA Programme Clinical Evaluation and Trials proposal has been funded to assess the effectiveness of shared care for patients with neovascular age related macular degeneration. I devised a qualitative component as part of this proposal to determine the views of health professionals and patients on the devolving of monitoring from hospital based ophthalmologists to community based optometrists to assess the need for re-treatment.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Liverpool</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Eye and Vision Science</gtr:department><gtr:description>The ECHoES trial</gtr:description><gtr:id>845104FE-35C1-4EF6-9D50-35492A02F2A6</gtr:id><gtr:impact>An NIHR HTA Programme Clinical Evaluation and Trials proposal was accepted for funding and is currently being undertaken. Multidisciplinary collaboration involving: ophthalomology, health services research, health economics, epidemiology, vision and vascular science, qualitative research</gtr:impact><gtr:outcomeId>Ubg6TNKTKgU-3</gtr:outcomeId><gtr:partnerContribution>Collectively the partners put together an HTA proposal to assess the effectiveness of community versus hospital eye service follow-up for patients with neovascular age related macular degeneration.</gtr:partnerContribution><gtr:piContribution>An NIHR HTA Programme Clinical Evaluation and Trials proposal has been funded to assess the effectiveness of shared care for patients with neovascular age related macular degeneration. I devised a qualitative component as part of this proposal to determine the views of health professionals and patients on the devolving of monitoring from hospital based ophthalmologists to community based optometrists to assess the need for re-treatment.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC All-Ireland Hub for Trials Methodology Research</gtr:department><gtr:description>MRC Hubs for Trials Methodology Research Trial Recruitment Working Group</gtr:description><gtr:id>6F9E10FA-F164-4DBC-90D4-93F4BD0B308D</gtr:id><gtr:impact>Document on &amp;quot;Tips for optimising recruitment of patients to randomised clinical trials&amp;quot;; national cross hub workshop on recruitment into surgical trials; national cross hub workshop on the value of integrating qualitative research in randomised trials; session on trial recruitment at the National HTMR annual meeting; preparation for a forthcoming national cross hub workshop with clinical trial unit directors on recruitment and retention in randomised trials.</gtr:impact><gtr:outcomeId>Vi9EUEQ5sCo-5</gtr:outcomeId><gtr:partnerContribution>Contributed to all outputs to date</gtr:partnerContribution><gtr:piContribution>I lead and contribute to the working group</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Edinburgh Hub for Trials Methodology Research</gtr:department><gtr:description>MRC Hubs for Trials Methodology Research Trial Recruitment Working Group</gtr:description><gtr:id>18135CBB-6120-4CFD-B911-10E5CEF8167C</gtr:id><gtr:impact>Document on &amp;quot;Tips for optimising recruitment of patients to randomised clinical trials&amp;quot;; national cross hub workshop on recruitment into surgical trials; national cross hub workshop on the value of integrating qualitative research in randomised trials; session on trial recruitment at the National HTMR annual meeting; preparation for a forthcoming national cross hub workshop with clinical trial unit directors on recruitment and retention in randomised trials.</gtr:impact><gtr:outcomeId>Vi9EUEQ5sCo-2</gtr:outcomeId><gtr:partnerContribution>Contributed to all outputs to date</gtr:partnerContribution><gtr:piContribution>I lead and contribute to the working group</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bristol</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Social and Community Medicine</gtr:department><gtr:description>MRC ConDuCT Hub - Hub in Trial Methodology Research</gtr:description><gtr:id>06CD6ABB-A320-4C70-878C-91881C8135E0</gtr:id><gtr:impact>The ConDuCT Hub proposal to the MRC was successful and research is currently underway. My involvement has so far resulted in publications, funded research (SMILE feasibility trial, ECHoES trial), running a national workshop to highlight and discuss the importance of qualitative research within trials and giving presentations on findings from my fellowship research. Multi-disciplinary collaboration involving: qualitative research, statistics, health economics, health services research and epidemiology</gtr:impact><gtr:outcomeId>B8D32448AC9-1</gtr:outcomeId><gtr:partnerContribution>Colleagues from the former Department of Community Based Medicine contributed their expertise to the ConDuCT Hub proposal. In particular, results from their research were combined with results from my research and those of my departmental colleagues to support the need for the ConDuCT Hub proposal and to clarify the aims, objectives and design of the research</gtr:partnerContribution><gtr:piContribution>Findings from my MRC fellowship highlighted the importance of integrating qualitative research within trials, and especially the importance of using more novel methods of analysis (recordings of recruitment appointments) to investigate and overcome recruitment difficulties in RCTs. This work arising from my fellowship contributed to the set up of a formal collaboration with colleagues within and across departments and a proposal to set up a ConDuCT Hub to develop innovative research methods for the design and delivery of RCTs under the umbrella of the Hubs for Trials Methodology research (HTMR).</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen's University Belfast</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Public Health (CPH)</gtr:department><gtr:description>The ECHoES trial</gtr:description><gtr:id>C17A61D9-24BA-4775-96CA-DEF6E2AF904D</gtr:id><gtr:impact>An NIHR HTA Programme Clinical Evaluation and Trials proposal was accepted for funding and is currently being undertaken. Multidisciplinary collaboration involving: ophthalomology, health services research, health economics, epidemiology, vision and vascular science, qualitative research</gtr:impact><gtr:outcomeId>Ubg6TNKTKgU-5</gtr:outcomeId><gtr:partnerContribution>Collectively the partners put together an HTA proposal to assess the effectiveness of community versus hospital eye service follow-up for patients with neovascular age related macular degeneration.</gtr:partnerContribution><gtr:piContribution>An NIHR HTA Programme Clinical Evaluation and Trials proposal has been funded to assess the effectiveness of shared care for patients with neovascular age related macular degeneration. I devised a qualitative component as part of this proposal to determine the views of health professionals and patients on the devolving of monitoring from hospital based ophthalmologists to community based optometrists to assess the need for re-treatment.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Oral presentation at conference</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1B5BCC09-36E6-4956-BB0D-F2829FD8A234</gtr:id><gtr:impact>Mills N. Oral presentation at Society for Clinical Trials conference in Boston in May 2013 ?An introduction to qualitative research methods in clinical trials? as part of an invited speaker session ? ?Can Qualitative Research Methods Revolutionize the Design and Conduct of Randomized Clinical Trials??

Education impact at present with plans for a paper</gtr:impact><gtr:outcomeId>oanAh3mrd7Q</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oral presentation at conference</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B8B4E248-19EA-446D-A960-C2A29C1438F9</gtr:id><gtr:impact>Mills N. &amp;quot;The role of patient treatment preferences in improving trial recruitment: evidence from the ProtecT trial&amp;quot;. British Thoracic Oncology Group; Dublin. Attended by over 400 delegates

Educational output at present</gtr:impact><gtr:outcomeId>AL57iuh826y</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Workshop</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>75ECEA32-1017-4670-90C5-26C04F2C7356</gtr:id><gtr:impact>Mills H, Heawood A, Donovan J. Organised and ran the course &amp;quot;How qualitative methods can contribute to the design and conduct of randomised trials - A University of Bristol School of Social and Community Medicine course in conjunction with ConDuCT Hub (20 March 2012 and 18 June 2013).

Educational impact at present</gtr:impact><gtr:outcomeId>M8uKiAdx8Yy</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012,2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>381646</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR HTA programme clinical evaluation and trials - ECHoES trial</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>61160A41-87C9-417D-8A54-2BCC5ABD178A</gtr:id><gtr:outcomeId>R4ef4vVHnh4</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>16052</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Network of Hubs for Trials Methodology Research (HTMR) funding- workshop on recruitment and retention in trials</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>0ACAA79D-904F-480D-822C-1431367E506B</gtr:id><gtr:outcomeId>BnFQqwS5HYA</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5472</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Network of Hubs for Trials Methodology Research (HTMR)</gtr:department><gtr:description>MRC HTMR small study funding - Workshop on clinical trials in head and neck cancer.</gtr:description><gtr:end>2014-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>07CD425C-2692-4EAE-9D31-9ECBC8328C03</gtr:id><gtr:outcomeId>SZcFyTiVUec</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>164000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Linbury Trust</gtr:department><gtr:description>Linbury Trust and Ashden Trust Project Grant - SMILE feasibility and main trial</gtr:description><gtr:fundingOrg>The Sainsbury Family Charitable Trusts</gtr:fundingOrg><gtr:id>A514D641-68D8-4351-A38D-341D37825069</gtr:id><gtr:outcomeId>9C2542B43320</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Qualitative research in trials national workshop</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EE66530D-5314-4FBA-A055-D5C54ABB8E60</gtr:id><gtr:outcomeId>Cz7t84Tu1Rs</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>644850FF-E79A-4FFD-9652-3C78DFB2CB47</gtr:id><gtr:title>Exploring inequalities in access to care and the provision of choice to women seeking breast reconstruction surgery: a qualitative study.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/217edbad5ea0e4d19bb1e17ecd503e55"><gtr:id>217edbad5ea0e4d19bb1e17ecd503e55</gtr:id><gtr:otherNames>Potter S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>doi_14310_c_2013_461</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F870FD1D-D372-4F67-9A96-C97149794ABD</gtr:id><gtr:title>A comparison of socio-demographic and psychological factors between patients consenting to randomisation and those selecting treatment (the ProtecT study).</gtr:title><gtr:parentPublicationTitle>Contemporary clinical trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/131290eb61bf5bf74038ca79e8512782"><gtr:id>131290eb61bf5bf74038ca79e8512782</gtr:id><gtr:otherNames>Mills N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1551-7144</gtr:issn><gtr:outcomeId>AFA5CC860D7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7CECC29-196F-45DF-B696-214B8CE20040</gtr:id><gtr:title>Training recruiters to randomized trials to facilitate recruitment and informed consent by exploring patients' treatment preferences.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/131290eb61bf5bf74038ca79e8512782"><gtr:id>131290eb61bf5bf74038ca79e8512782</gtr:id><gtr:otherNames>Mills N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>544670df503ce8.68728749</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F78D1081-7318-449A-A203-13A13CB7D30B</gtr:id><gtr:title>Assessment of cosmesis after breast reconstruction surgery: a systematic review.</gtr:title><gtr:parentPublicationTitle>Annals of surgical oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/217edbad5ea0e4d19bb1e17ecd503e55"><gtr:id>217edbad5ea0e4d19bb1e17ecd503e55</gtr:id><gtr:otherNames>Potter S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1068-9265</gtr:issn><gtr:outcomeId>pm_14310_20_20972633</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05E9C6FB-77B3-4CED-869D-08C25EED8A52</gtr:id><gtr:title>Adolescents and mothers value referral to a specialist service for chronic fatigue syndrome or myalgic encephalopathy (CFS/ME).</gtr:title><gtr:parentPublicationTitle>Primary health care research &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/363577bbb693d36e9ba386ee1900c695"><gtr:id>363577bbb693d36e9ba386ee1900c695</gtr:id><gtr:otherNames>Beasant L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1463-4236</gtr:issn><gtr:outcomeId>pm_14310_20_23731646</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60C11FC8-4885-4264-9B4E-5D200C741F48</gtr:id><gtr:title>Exploring treatment preferences facilitated recruitment to randomized controlled trials.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/131290eb61bf5bf74038ca79e8512782"><gtr:id>131290eb61bf5bf74038ca79e8512782</gtr:id><gtr:otherNames>Mills N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn><gtr:outcomeId>sk873q2pm3h</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G106/1092</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>E8160779-C41E-46F6-B795-59C27D6B2E2B</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>4.3  Influences and impact</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>